MedTech Spectrum

Article Name Clinical & Diagnostic

“Rapid evolution of technologies, biopharmaceuticals, and genomic medicine are reshaping the healthcare sector”

Terumo India, the Indian arm of Japan-based medtech firm Terumo Corporation, has recently announced the launch of new medical tools, intended for use in the management of liver cancer. With World Cancer Day, on February 4, 2024, calling to improve prevention, detection and treatment of cancer, new products are being launched in the Indian market to shape a way forward. MedTech Spectrum & BioSpectrum India spoke to Shishir Agarwal, President and Managing Director, Terumo India about the current scenario of the oncology medical devices market in the country.

02nd February, 2024

NeoLacta Life Sciences makes significant Impact, Touching lives of 1 Lakh preterm infants in India

Transforming the Lives of 1 Lakh Preterm Infants in India through Innovative Healthcare Solutions

30th January, 2024

SBI General Insurance Collaborates with IIT Madras to Pioneer Affordable Breast Cancer Treatment Device in India

SBI General Insurance has embarked on a transformative journey in healthcare innovation by partnering with the Indian Institute of Technology Madras (IIT Madras) through the Corporate Social Responsibility (CSR) initiative. The program aims to empower the development of a Thermal Therapy Device, set to revolutionize the treatment landscape for breast cancer patients.

30th January, 2024

Beckman Coulter Introduces DxC 500 AU Chemistry Analyzer, Enhances Portfolio with Six Sigma Performance

New analyzer complements hub labs by advancing capabilities of satellite and independent community hospital labs

30th January, 2024

Enhatch Receives FDA Clearance for AI-Enhanced TKA Instrumentation System

Enhatch Inc. is excited to announce the U.S. Food and Drug Administration (FDA) 510(k) clearance of a patient specific instrumentation system for Total Knee Arthroplasty. This state-of-the-art system is redefining total knee arthroplasty with its AI-driven approach, encompassing both anatomic model generation and treatment planning

26th January, 2024

BD Advances Women's Health Equity in Kenya with Cancer Screening

Collaboration with Kenya Ministry of Health National Cancer Institute Aims to Expand Access to Diagnostics, Reduce Cervical Cancer Rates

26th January, 2024

Olympus Closes the Acquisition of Korean Gastrointestinal Stent Company, Taewoong Medical Co., Ltd

Olympus Strengthens its Medical Portfolio with Successful Acquisition of Taewoong Medical Co., Ltd, a Leading Korean Gastrointestinal Stent Company

24th January, 2024

Veeva Pulse Shows Doctors Opening Up Two-Way Communications Doubles Digital Engagement

Digital channels are emerging as the preferred method for engagement with field teams in Asia

24th January, 2024

Brain Navi Announces 100th Surgical Procedure Completed Using NaoTrac

Brain Navi Celebrates Milestone Achievement: Successfully Completes 100 Surgical Procedures with NaoTrac Navigation System

18th January, 2024

UNFO Introduces Innovative Corrective Foot Brace For Newborns, Elevating Pediatric Orthopedic Care In The U.S.

Israeli Doctor Revolutionizes Treatment for Metatarsus Adductus (MTA) in Newborns, Replacing The Need For Casting And Surgical Intervention

17th January, 2024

“The Open Innovation Program has become a trend in the molecular diagnostics industry”

Established in 2000, South Korea based Seegene Inc is a leader in molecular diagnostics and achieved remarkable financial success with over $1 billion in revenue and 65 per cent gross margins. With a mission for a disease-free world and proactive pandemic prevention, Seegene seamlessly integrates high multiplex diagnostic assays with automated testing systems. In an interaction with BioSpectrum & MedTech Spectrum, Dr Seong-Youl Kim, Seegene's Senior Vice President, shares insights on the company, the molecular diagnostics landscape, challenges and opportunities etc.

08th January, 2024

Targeted Battle Against HPV

Since the launch of the global strategy against cervical cancer in 2020, the World Health Organization (WHO) has accelerated the initiative by virtue of commitments and strategies offered by governments and organisations worldwide. Australia is on track to become one of the first nations to achieve this, and countries like Bangladesh and Indonesia have introduced HPV vaccines. Let's examine Asia's efforts in eliminating cervical cancer and whether the continent is on track to meet WHO’s targets by 2030.

08th January, 2024

Varian & Nova Scotia Health Forge Groundbreaking Oncology Partnership for Cancer Care Advancements

Varian, a Siemens Healthineers company, and Nova Scotia Health have formed an unprecedented 10-year, $175 million CAD multi-disciplinary oncology partnership (MDOP) designed to deliver value across the Nova Scotia Health system by accelerating the patient journey from screening to survivorship.

05th January, 2024

Lucem Health Launches Reveal for Faster AFib-Related Stroke Treatment

Groundbreaking Solution Identifies Undiagnosed AFib and Speeds Treatments Proven to Prevent Strokes

18th December, 2023

TMRW Life Sciences Expands Globally Entering UK Fertility Market

The Hewitt Fertility Centre is the First UK Clinic to Adopt TMRW's State-of-the-Art Technology for the Safe Management of Frozen Eggs and Embryos Providing a New Standard of Care for Fertility Patients

18th December, 2023

Nestlé Study: Optifast® Meal Replacement Reduces Weight and Cardiovascular Risks

For the 4 in 10 U.S. adults living with obesity, and therefore at increased risk of heart disease,1 Optifast is a non-invasive option to potentially lose weight and preserve heart health

18th December, 2023